We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
-8.17%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$218M
AUM Growth
-$19.5M
(-8.2%)
Cap. Flow
+$3.51M
Cap. Flow
% of AUM
1.61%
Top 10 Holdings %
Top 10 Hldgs %
4.42%
Holding
1,001
New
307
Increased
177
Reduced
167
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$934K |
| 2 |
MASI
Masimo
MASI
|
+$931K |
| 3 |
Palladyne AI
PDYN
|
+$929K |
| 4 |
Equity Lifestyle Properties
ELS
|
+$926K |
| 5 |
BorgWarner
BWA
|
+$898K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carlyle Group
CG
|
+$962K |
| 2 |
GeneDx Holdings
WGS
|
+$933K |
| 3 |
Viasat
VSAT
|
+$852K |
| 4 |
INFA
Informatica
INFA
|
+$807K |
| 5 |
Amgen
AMGN
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.61% |
| 2 | Technology | 17.16% |
| 3 | Industrials | 15.49% |
| 4 | Financials | 11.59% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NNDM
601
Nano Dimension
NNDM
$309M
| $134K | 0.06% |
84,563
+17,914
| +27% | +$40.6K |
|
|
DFTX
602
Definium Therapeutics
DFTX
$5.73B
| $133K | 0.06% |
+22,708
| New | +$163K |
|
603
Coty
COTY
$2.33B
| $133K | 0.06% |
+24,282
| New | +$152K |
|
604
LSB Industries
LXU
$881M
| $131K | 0.06% |
+19,920
| New | +$155K |
|
605
Digimarc Corp
DMRC
$133M
| $131K | 0.06% |
+10,190
| New | +$291K |
|
|
ACH
606
Accendra Health
ACH
$240M
| $126K | 0.06% |
+13,954
| New | +$147K |
|
607
NET Power
NPWR
$125M
| $126K | 0.06% |
+47,794
| New | +$337K |
|
608
Vale
VALE
$62.9B
| $123K | 0.06% |
12,334
+30
| +0.2% | +$283 |
|
609
Viemed Healthcare
VMD
$451M
| $114K | 0.05% |
15,706
+4,232
| +37% | +$33.2K |
|
610
Nomura Holdings
NMR
$28.7B
| $114K | 0.05% |
18,570
-6,817
| -27% | -$43.4K |
|
611
NerdWallet
NRDS
$584M
| $114K | 0.05% |
+12,597
| New | +$151K |
|
612
Butterfly Network
BFLY
$1.72B
| $109K | 0.05% |
+47,715
| New | +$171K |
|
613
Target Hospitality
TH
$1.61B
| $108K | 0.05% |
+16,447
| New | +$132K |
|
614
Nokia
NOK
$50.8B
| $107K | 0.05% |
+20,269
| New | +$99.2K |
|
615
Annexon
ANNX
$855M
| $103K | 0.05% |
+53,271
| New | +$177K |
|
|
VLRS
616
Controladora Vuela Compania de Aviacion
VLRS
$876M
| $103K | 0.05% |
19,639
-1,179
| -6% | -$8.47K |
|
617
EverCommerce
EVCM
$2.05B
| $102K | 0.05% |
+10,147
| New | +$103K |
|
618
PagSeguro Digital
PAGS
$2.57B
| $102K | 0.05% |
13,338
-6,187
| -32% | -$46K |
|
619
Candel Therapeutics
CADL
$700M
| $101K | 0.05% |
+17,907
| New | +$146K |
|
620
Fortrea Holdings
FTRE
$1.85B
| $98.6K | 0.05% |
+13,059
| New | +$184K |
|
621
Ultrapar
UGP
$6.87B
| $94.7K | 0.04% |
30,747
-65,433
| -68% | -$188K |
|
622
Clover Health Investments
CLOV
$2.28B
| $92.7K | 0.04% |
25,827
+13,688
| +113% | +$55K |
|
|
ACRE
623
Ares Commercial Real Estate
ACRE
$252M
| $92.4K | 0.04% |
+19,965
| New | +$106K |
|
|
OLPX
624
DELISTED
Olaplex Holdings
OLPX
| $87.7K | 0.04% |
69,027
+4,584
| +7% | +$6.78K |
|
625
RLJ Lodging Trust
RLJ
$1.87B
| $81.8K | 0.04% |
10,365
-3,294
| -24% | -$30.9K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2025 Portfolio in Review
As of Q1 2025, EntryPoint Capital held 1,001 positions worth $218M, down 8.2% from $238M the previous quarter. Its ten largest holdings account for 4.4% of the portfolio.
EntryPoint Capital's Q1 2025 filing shows 307 new, 177 increased, 167 reduced and 349 closed positions. Its largest new stake was AtriCure: 25,168 shares worth $812K. The largest sale was Carlyle Group, an estimated $962K.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
- EntryPoint Capital's largest Q1 2025 buy was AtriCure: 25,168 shares worth $812K.
- EntryPoint Capital added most to Amphenol in Q1 2025, an estimated $815K increase.
- EntryPoint Capital's biggest Q1 2025 reduction was Harmony Biosciences, cutting an estimated $692K.
- EntryPoint Capital fully exited Carlyle Group in Q1 2025, selling an estimated $962K.
- EntryPoint Capital's ten largest holdings make up 4.4% of its $218M portfolio in Q1 2025.
- EntryPoint Capital opened 307 new positions and closed 349 in Q1 2025.
- EntryPoint Capital's portfolio value fell 8.2% quarter-over-quarter to $218M.
Based on EntryPoint Capital's 13F filing for Q1 2025, filed 14 May 2025.